8440 related articles for article (PubMed ID: 19232159)
1. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
2. The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.
Bikle DD; Rasmussen H
J Clin Invest; 1975 Feb; 55(2):292-8. PubMed ID: 236326
[TBL] [Abstract][Full Text] [Related]
3. Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol.
Bulla M; Delling G; Offermann G; Ziegler R; Benz G; Lühmann H; Sanchez de Reutter A; Severin M
Proc Eur Dial Transplant Assoc; 1979; 16():644-8. PubMed ID: 232917
[TBL] [Abstract][Full Text] [Related]
4. Does long term haemofiltration provoke secondary hyperparathyroidism?
Schneider H; Streicher E; Schmidt-Gayk H; Bosnjakovic S
Proc Eur Dial Transplant Assoc; 1978; 15():532-9. PubMed ID: 740684
[TBL] [Abstract][Full Text] [Related]
5. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
[TBL] [Abstract][Full Text] [Related]
6. Neurodiagnostic abnormalities in patients with acute renal failure.
Cooper JD; Lazarowitz VC; Arieff AI
J Clin Invest; 1978 Jun; 61(6):1448-55. PubMed ID: 659607
[TBL] [Abstract][Full Text] [Related]
7. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
Ritz E; Kreusser W; Boland R; Bommer J
Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology.
Malluche HH; Ritz E; Werner E; Meyer-Sabellek WA
Clin Nephrol; 1978 Dec; 10(6):219-28. PubMed ID: 215365
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
[TBL] [Abstract][Full Text] [Related]
10. [Calcium and phosphorus metabolism in patients on chronic intermittent haemodialysis with different calcium concentrations in the dialysate (author's transl)].
Kovarik J; Graf H; Stummvoll HK; Wolf A; Pinggera W
Wien Klin Wochenschr; 1979 Nov; 91(22):765-8. PubMed ID: 516748
[TBL] [Abstract][Full Text] [Related]
11. Interventions for metabolic bone disease in children with chronic kidney disease.
Hahn D; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008327. PubMed ID: 26561037
[TBL] [Abstract][Full Text] [Related]
12. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3.
Massry SG; Tuma S; Dua S; Goldstein DA
J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells.
Trechsel U; Bonjour JP; Fleisch H
J Clin Invest; 1979 Jul; 64(1):206-17. PubMed ID: 109470
[TBL] [Abstract][Full Text] [Related]
14. Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis.
Thadhani RI; Rosen S; Ofsthun NJ; Usvyat LA; Dalrymple LS; Maddux FW; Hymes JL
Clin J Am Soc Nephrol; 2020 Mar; 15(3):384-391. PubMed ID: 32111702
[TBL] [Abstract][Full Text] [Related]
15. [Corneal deposits in children on dialysis and treatment with vitamin D3 and 1,25 DHCC (author's transl)].
Severin M; Bulla M
Klin Monbl Augenheilkd; 1979 Nov; 175(5):670-6. PubMed ID: 232733
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
17. [Primary hyperparthyroidism. Analysis of 152 patients with special reference to acute life threatening complications (acute hyperparathyroidism)].
Kistler H
Schweiz Med Wochenschr Suppl; 1976; (3):1-61. PubMed ID: 208139
[TBL] [Abstract][Full Text] [Related]
18. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
Short E; Morris RC; Sebastian A; Spencer M
J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
[TBL] [Abstract][Full Text] [Related]
19. [1 alpha-hydroxyvitamin D3: chemical synthesis and biological effect].
Bauman VK; Bogoslovskiĭ NA; Kisel'nikova TA; Shakhova MK; Valinietse MIu
Prikl Biokhim Mikrobiol; 1978; 14(2):243-52. PubMed ID: 208064
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D-resistant rickets. A prototype of nutritional management of a genetic disorder.
Deluca HF
Curr Concepts Nutr; 1979; 8():3-32. PubMed ID: 230941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
